The agency expects existing programs to guide its regulation, adding that modified portions of animal genomes would be considered drugs.
The Genomics Evidence Neoplasia Information Exchange aims to provide insights through the analysis of data from tens if not hundreds of thousands of patient results.
The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.
Key provisions of the legislation include additional funding for key National Institutes of Health programs, as well as a streamlining of the US Food and Drug Administration's approval process.
New York Governor Andrew Cuomo and New York City Mayor Bill de Blasio unveiled two initiatives that will provide funding and tax incentives for life sciences research and industry.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.